Panic attack-like episodes possibly associated with ropinirole.
Alonso-Navarro
Hortensia
H
Jiménez-Jiménez
Félix Javier
FJ
Pilo-de-la-Fuente
Belén
B
Plaza-Nieto
José Francisco
JF
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D016584:Panic Disorder / Q000139:chemically induced* / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole